Clinical features and survival in pediatric oncohematological patients with COVID-19 in a referral Hospital of Peruvian Social Health Insurance, during 2020-2021
DOI:
https://doi.org/10.35434/rcmhnaaa.2023.161.1702Keywords:
COVID-19, Neoplasms, leukemia, Child, Pediatrics, PeruAbstract
Introduction: In Latin America, there are few studies and heterogeneous results on pediatric oncohematology patients with COVID-19. Objective: To describe the clinical characteristics and survival of pediatric oncohematology patients with COVID-19 in a hospital in Lima-Peru, 2020-2021. Methods: Retrospective longitudinal study of hospitalized patients under 14 years of age. The data was collected from the medical records. Results: We included 30 patients, mostly men and schoolchildren, predominantly fever, respiratory and gastrointestinal symptoms, hematological neoplasia, and advanced oncological disease. The majority developed mild-moderate disease, but they also presented severe evolution requiring critical areas, with high mortality in hospitalization (13.3%) and low survival during follow-up (at 526 days, 59.26%, 95% CI 36 .53 to 76.20%). Survival increased with the start of chemotherapy, and decreased in patients in palliative condition, with respiratory support and shock. Conclusion: Most developed mild-moderate disease. However, SARS-CoV-2 can also cause severe involvement, death, and poor survival in oncohematological patients.
Downloads
Metrics
References
Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, et al. Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis. Int J Infect Dis. 2021;103:246-56. doi: 10.1016/j.ijid.2020.11.163
Węcławek-Tompol J, Zakrzewska Z, Gryniewicz-Kwiatkowska O, Pierlejewski F, Bień E, Zaucha-Prażmo A, et al. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study. J Hematol Oncol. 2021;14(1):163. doi: 10.1186/s13045-021-01181-4
Global Health Research Group on Children’s Non-Communicable Diseases Collaborative. Impact of the COVID-19 pandemic on patients with paediatric cancer in low-income, middle-income and high-income countries: a multicentre, international, observational cohort study. BMJ Open. 2022;12(4):e054690. doi: 10.1136/bmjopen-2021-054690
Johnston EE, Martinez I, Davis ES, Caudill C, Richman J, Brackett J, et al. SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities. J Clin Oncol. 2021;39(34):3778-88. doi: 10.1200/JCO.21.00702
Mukkada S, Bhakta N, Chantada GL, Chen Y, Vedaraju Y, Faughnan L, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021;22(10):1416-26. doi: 10.1016/S1470-2045(21)00454-X
Dorantes-Acosta E, Ávila-Montiel D, Klünder-Klünder M, Juárez-Villegas L, Márquez-González H. Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis. Front Oncol. 2020;10:608282. doi: 10.3389/fonc.2020.608282
Meena JP, Kumar Gupta A, Tanwar P, Ram Jat K, Mohan Pandey R, Seth R. Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review. Pediatr Blood Cancer. 2021;68(6):e29005. doi: 10.1002/pbc.29005
Majeed A, Wright T, Guo B, Arora RS, Lam CG, Martiniuk AL. The Global Impact of COVID-19 on Childhood Cancer Outcomes and Care Delivery - A Systematic Review. Front Oncol. 2022;12:869752. doi: 10.3389/fonc.2022.869752
Schlage S, Lehrnbecher T, Berner R, Simon A, Toepfner N. SARS-CoV-2 in pediatric cancer: a systematic review. Eur J Pediatr. 2022;181(4):1413-27. doi: 10.1007/s00431-021-04338-y
Palomo-Collí MÁ, Fuentes-Lugo AD, Cobo-Ovando SR, Juárez-Villegas L. COVID-19 in Children and Adolescents With Cancer From a Single Center in Mexico City. J Pediatr Hematol Oncol. 2021;43(7):e1047-8. doi: 10.1097/MPH.0000000000002040
Lima ALM de A, Borborema M do CD, Matos APR, Oliveira KMM de, Mello MJG, Lins MM. COVID-19 cohort on children with cancer: delay in treatment and increased frequency of deaths. Rev Bras Saúde Materno Infant. 2021;21:299-304. doi: 10.1590/1806-9304202100S100017
Sánchez-Jara B, Torres-Jiménez AR, Del Campo-Martinez M de los A, Ortíz-Torres MG, García-Soto A, Loza-Santiaguillo P del R, et al. Clinical characteristics and evolution of pediatric patients with acute leukemia and SARS-COV2 virus infection in a third level hospital in Mexico. Pediatr Hematol Oncol J. 2021;6(1):42-8. doi: 10.1016/j.phoj.2020.11.001
Fonseca EV, Pardo CA, Linares A, López JF, Camacho G, Aponte NH, et al. Clinical Characteristics and Outcomes of a Cohort of Pediatric Oncohematologic Patients With COVID-19 Infection in the City of Bogotá, Colombia. Pediatr Infect Dis J. 2021;40(6):499-502. doi: 10.1097/INF.0000000000003135
Corso MCM, Soares VJ, Amorim AMP, Cipolotti R, Magalhães IMQ, Lins MM, et al. SARS-CoV-2 in children with cancer in Brazil: Results of a multicenter national registry. Pediatr Blood Cancer. 2021;68(12):e29223. doi: 10.1002/pbc.29223
Dominguez-Rojas JÁ, Vásquez-Hoyos P, Pérez-Morales R, Monsalve-Quintero AM, Mora-Robles L, Diaz-Diaz A, et al. Association of Cancer Diagnosis and Therapeutic Stage With Mortality in Pediatric Patients With COVID-19, Prospective Multicenter Cohort Study From Latin America. Front Pediatr. 2022;10:885633. doi: 10.3389/fped.2022.885633
Nicastro E, Verdoni L, Bettini LR, Zuin G, Balduzzi A, Montini G, et al. COVID-19 in Immunosuppressed Children. Front Pediatr. 2021;9:629240. doi: 10.3389/fped.2021.629240
The World Bank. The World by Income and Region [Internet]. [citado 10 de noviembre de 2022]. Disponible en: https://datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html
Herrera-Añazco P, Uyen-Cateriano A, Mezones-Holguin E, Taype-Rondan A, Mayta-Tristan P, Malaga G, et al. Some lessons that Peru did not learn before the second wave of COVID-19. Int J Health Plann Manage. 2021;36(3):995-8. doi: 10.1002/hpm.3135
COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513-36. doi: 10.1016/S0140-6736(21)02796-3
Munayco CV, Tariq A, Rothenberg R, Soto-Cabezas GG, Reyes MF, Valle A, et al. Early transmission dynamics of COVID-19 in a southern hemisphere setting: Lima-Peru: February 29th–March 30th, 2020. Infect Dis Model. 2020;5:338-45. doi: 10.1016/j.idm.2020.05.001
Rouger-Gaudichon J, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, et al. COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE). Bull Cancer (Paris). 2021;108(5):490-500. doi: 10.1016/j.bulcan.2021.02.004
Bogaert B, Buisson V, Kozlakidis Z, Saintigny P. Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic. Crit Rev Oncol Hematol. 2022;173:103656. doi: 10.1016/j.critrevonc.2022.103656
Cesaro S, Ljungman P, Mikulska M, Hirsch HH, von Lilienfeld-Toal M, Cordonnier C, et al. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2022;36(6):1467-80. doi: 10.1038/s41375-022-01578-1
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Giancarlo Alvarado-Gamarra, Jesús Dominguez-Rojas, Noé Atamari-Anahui, Vanessa Zarate-Campos, Sarah Fernández Suárez, Eva Vásquez-Gamarra, Ninoska Rojas-Soto, Raquel Garcés-Ghilardi, Matilde Estupiñan-Vigil
This work is licensed under a Creative Commons Attribution 4.0 International License.
